Ivermectin for COVID - Breaking News


We have been talking about Ivermectin for a while now. This is an antiviral and anti parasite pharmaceutical that has saved more lives than any other drug, largely for it's antiparasitic action.


NIH (National Institutes of Health) Revises Treatment Guidelines for Ivermectin for the Treatment of COVID-19

Ivermectin is Now a Therapeutic Option for Doctors & Prescribers!

Source: https://covid19criticalcare.com/ (for inactive links on this blog - please go to this site)


Jan 14, 2021 – One week after Dr. Paul Marik and Dr. Pierre Kory – founding members of the Front Line Covid-19 Critical Care Alliance (FLCCC) – along with Dr. Andrew Hill, researcher and consultant to the World Health Organization (WHO), presented their data before the NIH Treatment Guidelines Panel, the NIH has upgraded their recommen­da­tion and now considers Ivermectin an option for use in COVID-19.

Their recommendation has now been upgraded to the same level as those for widely used monoclonal antibodies & convalescent plasma, which is a “neither for nor against” recommen­da­tion. The significance of this change is that the NIH has decided to no longer recommend against the use of ivermectin in the treatment of COVID-19 by the nation’s health care providers. A consequence of this change is that ivermectin has now been made a clear therapeutic option for patients.

Appearing as a witness on Dec. 8, 2020, before the Senate Committee on Homeland Security and Governmental Affairs—which held a hearing on “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution”— Dr. Pierre Kory, President of the Frontline COVID-19 Critical Care Alliance (FLCCC), called for the government to swiftly review the already expansive and still rapidly emerging medical evidence on Ivermectin.

Just as an aside, my mentor at Harvard, Dr. Clement Trempe, spend much of his 47-year clinical career helping people understand the cause(s) of glaucoma and memory loss. In the past week, I have consulted with several people with both glaucoma and root canals, which in many cases were installed because of P. gingivalis and other oral pathogen. You see, glaucoma is Alzheimer's of the eye and Alzheimer's is glaucoma of the brain. They are caused by the exact same pathology. Sometimes we trace these diseases back to poor oral health. In other cases, it is caused by an organism like the pathogen from Lyme disease or chlamydia pneumoniae - both of which there are inexpensive tests to measure their presence and burden.

Jan 7, 2021 – Press Release

FLCCC Alliance Invited to the NIH COVID-19 Treatment Guidelines Panel to Present Latest Data on Ivermectin

On January 6, 2021, our Drs. Pierre Kory and Paul Marik, founding members of the FLCCC Alliance, appeared before the National Institutes of Health COVID-19 Treatment Guidelines Panel to urge review of current data and an updated NIH guidance.

Dec 15, 2020 – now published:

Clinical and Scientific Rationale for the “MATH+” Hospital Treatment Protocol for COVID-19

FLCCC Alliance peer-reviewed paper published in the Journal of Intensive Care Medicine. The protocol described in this paper potentially offers a life-saving approach to the management of hospitalized COVID-19 patients. The MATH+ protocol offers an inexpensive combination of medicines with well-known safety profiles based on strong physiologic rationale and an increasing clinical evidence base.

“The I-MASK+ protocol will revolutionize the treatment of COVID-19”

Dr. Paul Marik (Oct. 30, 2020)

The Front Line COVID-19 Critical Care Alliance has now developed a prophylactic and early outpatient combination treatment protocol for COVID-19 called I-Mask+. This protocol is centered around the use of ivermectin, a well-known anti-parasite drug. Ivermectin has recently discovered anti-viral and anti-inflammatory properties and a rapidly growing published medical evidence base demonstrating its unique and highly potent ability to inhibit SARS-CoV-2 replication. Please visit these links to get the full picture:

  • I-MASK+ Prophylaxis & Early Outpatient Treatment Protocol for COVID-19

  • Our comprehensive review of the emerging evidence for Ivermectin use in our I-MASK+ protocol

  • A one-page summary of the scientific review on ivermectin above

  • Dr. Paul Marik’s comprehensive meta-analysis of COVID-19 therapeutics

  • An introductory video explaining the review on Ivermectin by Dr. Pierre Kory

  • Dr. Paul Marik’s recent lecture on I-MASK+

  • Invited Grand Rounds Lecture on ivermectin by Pierre Kory

In March, 2020 we first published our MATH+ Treatment Protocol for COVID-19, intended for hospitalized patients. The recently developed I-MASK+ Prophylaxis & Early Outpatient Treatment Protocol for COVID-19 is instead directed for use as a prophylaxis and in early outpatient treatment after contracting COVID-19. The protocols thus complement each other, and both are physiologic-based combination treatment regimens developed by leaders in critical care medicine. All component medicines are FDA-approved, inexpensive, readily available and have been used for decades with well-established safety profiles.

  • An FLCCC Alliance guide to the management of COVID-19 – An overview of the MATH+ and I-MASK+ protocols

I'm offering health coaching at a 10% discount. Order this service this month and get the following:

  • Highly skilled health coach consults - trained in our methods

  • A thirty minute consult with me to establish your needs and initial care plan to put the coach on the right path.

  • 6 hours of health coaching - on the following schedule"

An initial 1-hour consult

Fifteen 20-minute sessions every week or every other week to guide you on your path to better health.

  • Take or retake the Chronic Disease Assessment

  • Review your current treatment plan and labs

  • Have a healthy longevity!

https://www.healthrevivalpartners.com/product-page/6-health-revival-coaching-sessions-1


Stay Well







786 views0 comments